Dr. Reddy's Powers Up Talent with Fresh ESOP Share Allotment

In a strategic move to reinforce its commitment to talent and long-term growth, Dr. Reddy's Laboratories, a prominent player in the global pharmaceutical landscape, announced a significant allotment of equity shares to its dedicated employees.

The pharmaceutical giant confirmed on Tuesday, June 4, 2024, that it has successfully allotted 4,160 equity shares.

This latest distribution falls under the umbrella of the well-established Dr. Reddy's Employees Stock Option Scheme - 2018, designed to incentivize and align the interests of its valuable workforce with those of the company's shareholders.

Such employee stock option plans (ESOPs) are a widely recognized corporate strategy aimed at fostering a deeper sense of ownership and loyalty among employees.

By granting a stake in the company's future, Dr. Reddy's is not only rewarding past contributions but also encouraging sustained performance and dedication towards achieving collective goals. This initiative serves as a powerful tool for talent retention, ensuring that key personnel remain invested in the company's ongoing success.

The company meticulously followed all regulatory protocols, making the necessary filings with the Bombay Stock Exchange (BSE) to officially register this allotment.

This transparency underscores Dr. Reddy's adherence to corporate governance standards and its commitment to keeping stakeholders informed.

This allotment is a clear indication of Dr. Reddy's Laboratories' proactive approach to employee welfare and its belief in shared prosperity. By empowering its team members with a direct interest in the company's financial performance, Dr.

Reddy's aims to further strengthen its foundation, driving innovation and sustainable growth in the highly competitive pharmaceutical industry.